The store will not work correctly when cookies are disabled.
6-Aziridin-1-yl-2-phenyl-quinoline-5,8-dione
ID: ALA106284
PubChem CID: 24853733
Max Phase: Preclinical
Molecular Formula: C17H12N2O2
Molecular Weight: 276.30
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: O=C1C(N2CC2)=CC(=O)c2nc(-c3ccccc3)ccc21
Standard InChI: InChI=1S/C17H12N2O2/c20-15-10-14(19-8-9-19)17(21)12-6-7-13(18-16(12)15)11-4-2-1-3-5-11/h1-7,10H,8-9H2
Standard InChI Key: QVIFZZCONYCRNV-UHFFFAOYSA-N
Molfile:
RDKit 2D
21 24 0 0 0 0 0 0 0 0999 V2000
-0.9458 1.5625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.6583 1.9750 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.9458 0.7375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.4792 1.5625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.2333 1.9833 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.4792 0.7458 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.1917 0.3333 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.2333 0.3333 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.0750 2.6958 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.4833 1.9750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.9042 0.7458 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.1875 1.9750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.2333 2.8083 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.2333 -0.4917 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.9000 1.5708 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6167 0.3333 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3292 0.7458 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6167 -0.4917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3292 -0.9042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0417 0.3375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0417 -0.4917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 1 2 0
4 5 1 0
5 1 1 0
6 4 2 0
7 6 1 0
8 3 1 0
9 2 1 0
10 2 1 0
11 15 1 0
12 4 1 0
13 5 2 0
14 8 2 0
15 12 2 0
16 11 1 0
17 16 1 0
18 16 2 0
19 18 1 0
20 17 2 0
21 19 2 0
6 8 1 0
9 10 1 0
11 7 2 0
21 20 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 276.30 | Molecular Weight (Monoisotopic): 276.0899 | AlogP: 2.33 | #Rotatable Bonds: 2 |
Polar Surface Area: 50.04 | Molecular Species: NEUTRAL | HBA: 4 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 1.35 | CX LogP: 2.18 | CX LogD: 2.18 |
Aromatic Rings: 2 | Heavy Atoms: 21 | QED Weighted: 0.79 | Np Likeness Score: -0.08 |
References
1. Hargreaves R, David CL, Whitesell L, Skibo EB.. (2003) Design of quinolinedione-based geldanamycin analogues., 13 (18): [PMID:12941337] [10.1016/s0960-894x(03)00650-4] |
2. Hargreaves RH, David CL, Whitesell LJ, Labarbera DV, Jamil A, Chapuis JC, Skibo EB.. (2008) Discovery of quinolinediones exhibiting a heat shock response and angiogenesis inhibition., 51 (8): [PMID:18363347] [10.1021/jm7014099] |